Cargando…
Hypercholesterolemia‐Induced Loss of Flow‐Induced Vasodilation and Lesion Formation in Apolipoprotein E–Deficient Mice Critically Depend on Inwardly Rectifying K(+) Channels
BACKGROUND: Hypercholesterolemia‐induced decreased availability of nitric oxide (NO) is a major factor in cardiovascular disease. We previously established that cholesterol suppresses endothelial inwardly rectifying K(+) (Kir) channels and that Kir2.1 is an upstream mediator of flow‐induced NO produ...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866319/ https://www.ncbi.nlm.nih.gov/pubmed/29502106 http://dx.doi.org/10.1161/JAHA.117.007430 |
_version_ | 1783308825812533248 |
---|---|
author | Fancher, Ibra S. Ahn, Sang Joon Adamos, Crystal Osborn, Catherine Oh, Myung‐Jin Fang, Yun Reardon, Catherine A. Getz, Godfrey S. Phillips, Shane A. Levitan, Irena |
author_facet | Fancher, Ibra S. Ahn, Sang Joon Adamos, Crystal Osborn, Catherine Oh, Myung‐Jin Fang, Yun Reardon, Catherine A. Getz, Godfrey S. Phillips, Shane A. Levitan, Irena |
author_sort | Fancher, Ibra S. |
collection | PubMed |
description | BACKGROUND: Hypercholesterolemia‐induced decreased availability of nitric oxide (NO) is a major factor in cardiovascular disease. We previously established that cholesterol suppresses endothelial inwardly rectifying K(+) (Kir) channels and that Kir2.1 is an upstream mediator of flow‐induced NO production. Therefore, we tested the hypothesis that suppression of Kir2.1 is responsible for hypercholesterolemia‐induced inhibition of flow‐induced NO production and flow‐induced vasodilation (FIV). We also tested the role of Kir2.1 in the development of atherosclerotic lesions. METHODS AND RESULTS: Kir2.1 currents are significantly suppressed in microvascular endothelial cells exposed to acetylated–low‐density lipoprotein or isolated from apolipoprotein E–deficient (Apoe (−/−)) mice and rescued by cholesterol depletion. Genetic deficiency of Kir2.1 on the background of hypercholesterolemic Apoe (−/−)mice, Kir2.1 (+/−) /Apoe (−/−) exhibit the same blunted FIV and flow‐induced NO response as Apoe (−/−)or Kir2.1 (+/−) alone, but while FIV in Apoe (−/−) mice can be rescued by cholesterol depletion, in Kir2.1 (+/−) /Apoe (−/−) mice cholesterol depletion has no effect on FIV. Endothelial‐specific overexpression of Kir2.1 in arteries from Apoe (−/−) and Kir2.1 (+/−) /Apoe (−/−) mice results in full rescue of FIV and NO production in Apoe (−/−) mice with and without the addition of a high‐fat diet. Conversely, endothelial‐specific expression of dominant‐negative Kir2.1 results in the opposite effect. Kir2.1 (+/−) /Apoe (−/−)mice also show increased lesion formation, particularly in the atheroresistant area of descending aorta. CONCLUSIONS: We conclude that hypercholesterolemia‐induced reduction in FIV is largely attributable to cholesterol suppression of Kir2.1 function via the loss of flow‐induced NO production, whereas the stages downstream of flow‐induced Kir2.1 activation appear to be mostly intact. Kir2.1 channels also have an atheroprotective role. |
format | Online Article Text |
id | pubmed-5866319 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58663192018-03-28 Hypercholesterolemia‐Induced Loss of Flow‐Induced Vasodilation and Lesion Formation in Apolipoprotein E–Deficient Mice Critically Depend on Inwardly Rectifying K(+) Channels Fancher, Ibra S. Ahn, Sang Joon Adamos, Crystal Osborn, Catherine Oh, Myung‐Jin Fang, Yun Reardon, Catherine A. Getz, Godfrey S. Phillips, Shane A. Levitan, Irena J Am Heart Assoc Original Research BACKGROUND: Hypercholesterolemia‐induced decreased availability of nitric oxide (NO) is a major factor in cardiovascular disease. We previously established that cholesterol suppresses endothelial inwardly rectifying K(+) (Kir) channels and that Kir2.1 is an upstream mediator of flow‐induced NO production. Therefore, we tested the hypothesis that suppression of Kir2.1 is responsible for hypercholesterolemia‐induced inhibition of flow‐induced NO production and flow‐induced vasodilation (FIV). We also tested the role of Kir2.1 in the development of atherosclerotic lesions. METHODS AND RESULTS: Kir2.1 currents are significantly suppressed in microvascular endothelial cells exposed to acetylated–low‐density lipoprotein or isolated from apolipoprotein E–deficient (Apoe (−/−)) mice and rescued by cholesterol depletion. Genetic deficiency of Kir2.1 on the background of hypercholesterolemic Apoe (−/−)mice, Kir2.1 (+/−) /Apoe (−/−) exhibit the same blunted FIV and flow‐induced NO response as Apoe (−/−)or Kir2.1 (+/−) alone, but while FIV in Apoe (−/−) mice can be rescued by cholesterol depletion, in Kir2.1 (+/−) /Apoe (−/−) mice cholesterol depletion has no effect on FIV. Endothelial‐specific overexpression of Kir2.1 in arteries from Apoe (−/−) and Kir2.1 (+/−) /Apoe (−/−) mice results in full rescue of FIV and NO production in Apoe (−/−) mice with and without the addition of a high‐fat diet. Conversely, endothelial‐specific expression of dominant‐negative Kir2.1 results in the opposite effect. Kir2.1 (+/−) /Apoe (−/−)mice also show increased lesion formation, particularly in the atheroresistant area of descending aorta. CONCLUSIONS: We conclude that hypercholesterolemia‐induced reduction in FIV is largely attributable to cholesterol suppression of Kir2.1 function via the loss of flow‐induced NO production, whereas the stages downstream of flow‐induced Kir2.1 activation appear to be mostly intact. Kir2.1 channels also have an atheroprotective role. John Wiley and Sons Inc. 2018-03-03 /pmc/articles/PMC5866319/ /pubmed/29502106 http://dx.doi.org/10.1161/JAHA.117.007430 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Fancher, Ibra S. Ahn, Sang Joon Adamos, Crystal Osborn, Catherine Oh, Myung‐Jin Fang, Yun Reardon, Catherine A. Getz, Godfrey S. Phillips, Shane A. Levitan, Irena Hypercholesterolemia‐Induced Loss of Flow‐Induced Vasodilation and Lesion Formation in Apolipoprotein E–Deficient Mice Critically Depend on Inwardly Rectifying K(+) Channels |
title | Hypercholesterolemia‐Induced Loss of Flow‐Induced Vasodilation and Lesion Formation in Apolipoprotein E–Deficient Mice Critically Depend on Inwardly Rectifying K(+) Channels |
title_full | Hypercholesterolemia‐Induced Loss of Flow‐Induced Vasodilation and Lesion Formation in Apolipoprotein E–Deficient Mice Critically Depend on Inwardly Rectifying K(+) Channels |
title_fullStr | Hypercholesterolemia‐Induced Loss of Flow‐Induced Vasodilation and Lesion Formation in Apolipoprotein E–Deficient Mice Critically Depend on Inwardly Rectifying K(+) Channels |
title_full_unstemmed | Hypercholesterolemia‐Induced Loss of Flow‐Induced Vasodilation and Lesion Formation in Apolipoprotein E–Deficient Mice Critically Depend on Inwardly Rectifying K(+) Channels |
title_short | Hypercholesterolemia‐Induced Loss of Flow‐Induced Vasodilation and Lesion Formation in Apolipoprotein E–Deficient Mice Critically Depend on Inwardly Rectifying K(+) Channels |
title_sort | hypercholesterolemia‐induced loss of flow‐induced vasodilation and lesion formation in apolipoprotein e–deficient mice critically depend on inwardly rectifying k(+) channels |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866319/ https://www.ncbi.nlm.nih.gov/pubmed/29502106 http://dx.doi.org/10.1161/JAHA.117.007430 |
work_keys_str_mv | AT fancheribras hypercholesterolemiainducedlossofflowinducedvasodilationandlesionformationinapolipoproteinedeficientmicecriticallydependoninwardlyrectifyingkchannels AT ahnsangjoon hypercholesterolemiainducedlossofflowinducedvasodilationandlesionformationinapolipoproteinedeficientmicecriticallydependoninwardlyrectifyingkchannels AT adamoscrystal hypercholesterolemiainducedlossofflowinducedvasodilationandlesionformationinapolipoproteinedeficientmicecriticallydependoninwardlyrectifyingkchannels AT osborncatherine hypercholesterolemiainducedlossofflowinducedvasodilationandlesionformationinapolipoproteinedeficientmicecriticallydependoninwardlyrectifyingkchannels AT ohmyungjin hypercholesterolemiainducedlossofflowinducedvasodilationandlesionformationinapolipoproteinedeficientmicecriticallydependoninwardlyrectifyingkchannels AT fangyun hypercholesterolemiainducedlossofflowinducedvasodilationandlesionformationinapolipoproteinedeficientmicecriticallydependoninwardlyrectifyingkchannels AT reardoncatherinea hypercholesterolemiainducedlossofflowinducedvasodilationandlesionformationinapolipoproteinedeficientmicecriticallydependoninwardlyrectifyingkchannels AT getzgodfreys hypercholesterolemiainducedlossofflowinducedvasodilationandlesionformationinapolipoproteinedeficientmicecriticallydependoninwardlyrectifyingkchannels AT phillipsshanea hypercholesterolemiainducedlossofflowinducedvasodilationandlesionformationinapolipoproteinedeficientmicecriticallydependoninwardlyrectifyingkchannels AT levitanirena hypercholesterolemiainducedlossofflowinducedvasodilationandlesionformationinapolipoproteinedeficientmicecriticallydependoninwardlyrectifyingkchannels |